Riskpilot← Back to searchSign inGet full accessMOWI GENETICS AS
ASActiveOrg 922025045Sandviksbodene 77A, 5035 BergenResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20199 employeeswww.mowi.com
Revenue 2024
NOK 27,6M
-72% vs 2023
EBITDA margin
11.3%
-95% vs 2023
Equity ratio
36.8%
Financial strength
Net profit 2024
NOK 2,2M
-95% vs 2023
| Revenue | NOK 27,6M | -72% |
| EBITDA | NOK 3,1M | -95% |
| Net profit | NOK 2,2M | -95% |
| Total assets | NOK 27,8M | -66% |
| Equity | NOK 10,2M | -80% |
| Employees | 9 | — |
Legal name
MOWI GENETICS AS
Org number
922025045
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
8. januar 2019
Share capital
NOK 30 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Daglig leder alene.
Company purpose
Forskning, utvikling og drift tilknyttet oppdrettsvirksomhet, herunder salg av konsulenttjenester for genetikk innen akvakultur.
Address
Sandviksbodene 77A, 5035 Bergen
Phone
+4721562300
Email
norway@mowi.com
Website
www.mowi.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 38 072 | 38 324 | 38 744 | 99 139 | 27 609 |
| Staff expenses | −7 062 | −7 394 | −7 748 | −8 079 | −7 875 |
| EBITDA | 997 | 4 674 | −322 | 59 889 | 3 123 |
| Depreciation & amort. | −17 | −71 | −71 | −71 | −71 |
| EBIT | 980 | 4 603 | −392 | 59 818 | 3 052 |
| Net financials | −1 991 | −347 | −630 | −454 | −486 |
| Profit before tax | −1 012 | 4 256 | −1 023 | 59 364 | 2 566 |
| Tax | −350 | 792 | −225 | 12 494 | 416 |
| Net profit | −662 | 3 464 | −798 | 46 870 | 2 150 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 16 103 | 19 075 | 22 908 | 83 078 | 27 832 |
| Equity | 2 042 | 5 506 | 4 708 | 51 578 | 10 239 |
| Long-term debt | 43 | 49 | 0 | 49 | 45 |
| Short-term debt | 14 018 | 13 520 | 18 200 | 31 451 | 17 548 |
| Total debt | 14 061 | 13 569 | 18 200 | 31 500 | 17 593 |
EBITDA margin
11.3%
This company
15.8%
Market median
-28% vs market
20202024
Equity ratio
36.8%
This company
38.2%
Market median
+4% vs market
20202024
Return on equity
21.0%
This company
18.4%
Market median
+14% vs market
20202024
Net profit margin
7.8%
This company
8.1%
Market median
-4% vs market
20202024
Asset turnover
0.99×
This company
1.12×
Market median
+12% vs market
20202024
Debt / equity
1.72×
This company
0.62×
Market median
-177% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RH Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Former (1) | ||
| Chairman | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mowi Asa
MOWI GENETICS AS Board members of MOWI GENETICS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Roy Hjelmeland | Chief Executive Officer | 0 companies |
| Joachim Ulsrud | Chairman | 0 companies |
| Ane-Marte Sperre Rotevatn | Chairman | 0 companies |